Efficacy and Safety of Zolpidem Extended Release in Elderly Primary Insomnia Patients
Authors:
- 1 January 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 16 (1) , 44-57
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy and safety of zolpidem-MR: A double-blind, placebo-controlled study in adults with primary insomniaSleep Medicine, 2006
- A double‐blind, placebo‐controlled investigation of the residual psychomotor and cognitive effects of zolpidem‐MR in healthy elderly volunteersBritish Journal of Clinical Pharmacology, 2006
- Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenanceFundamental & Clinical Pharmacology, 2006
- Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoringPsychopharmacology, 2005
- ZolpidemCNS Drugs, 2005
- Long-Term, Non-Nightly Administration of Zolpidem in the Treatment of Patients With Primary InsomniaThe Journal of Clinical Psychiatry, 2004
- Comparative Pharmacokinetics and Pharmacodynamics of Short-Acting HypnosedativesClinical Pharmacokinetics, 2004
- Eight Weeks of Non-Nightly Use of Zolpidem for Primary InsomniaSLEEP, 2000
- Tolerance and rebound insomnia with rapidly eliminated hypnoticsInternational Clinical Psychopharmacology, 1999
- The safety and tolerability of zolpidem — an updateJournal of Psychopharmacology, 1999